In mid-2024, the Endocrine Society warned that online prescribing of compounded GLP-1s poses patient safety risks and undermines public confidence in obesity care. The organization called for stricter verification of clinicians and for oversight of digital compounding networks that have limited traceability or pharmacovigilance. Their concern echoed that of the FDA , which, after investigating multiple adverse-event reports linked to unapproved semaglutide, issued formal warnings to both compounders and telehealth distributors
In a 6-month trial of rhGH in GH-deficient adults, liver fat fraction fell from a mean of 12.4% to 7.8% (P 30, type 2 diabetes, or alcohol use disorder, add a FibroScan or hepatic ultrasound to establish a steatosis baseline before initiating therapy
Continuous variables were assessed using mean difference (MD) and corresponding 95% confidence intervals (CI), while dichotomous variables were assessed using combined odds ratio (OR) and corresponding 95% confidence intervals
"Whitening" implies changing skin tone itself, usually via melanin-suppressing actives
The drug also appeared to be safe and tolerable, with most adverse events being gastrointestinal and waning over time, similar to other GLP-1 medications
By understanding its benefits and who it is right for, you can make an informed decision about whether this treatment is suitable for you
